In silico study of synthetic Bromophenol Compounds against Staphylococcus aeurus's target protein (DHFR) Enzyme

The results demonstrated that the synthetic compound displayed a favorable binding affinity with the active site of the target protein DHFR enzyme (PDB ID: 2W9S) similar to the control (TMP).

📌 3 Key Takeaways

🎯

Objective & Hypothesis:Natural products (NPs) serve as prototypes for a majority of antimicrobial agents currently in clinical use.

📊

Key Findings & Data:DAP DHFR inhibitors have been used therapeutically for more over 30 years, and resistance to these drugs has grown prevalent.

💡

Conclusion & Impact:The results demonstrated that the synthetic compound displayed a favorable binding affinity with the active site of the target protein DHFR enzyme (PDB ID: 2W9S) similar to the control (TMP).

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Staphylococcus aeurus · Bromophenol · Staphylococcus aeurus

Abstract

Natural products (NPs) serve as prototypes for a majority of antimicrobial agents currently in clinical use. The evolutionary process that gives rise to these molecules is inevitably accompanied by resistance mechanisms that curtail the clinical lifespan of any given class of antibiotics. Staphylococcus aeurus is among the class of microorganisms that exhibit resistance to multiple drugs. Dihydrofolate reductase (DHFR) enzyme is a promising target in the pursuit of mitigating S. aureus infections. This enzyme catalyzes the formation of tetrahydrofolate (THF) through the reduction of Dihydrofolate (DHF) in the presence of nicotinamide adenine dinucleotide phosphate (NADPH). Diaminopyrimidines (DAPs), such as trimethoprim (TMP), a bacterial infection treatment, which is target DHFR. DAP DHFR inhibitors have been used therapeutically for more over 30 years, and resistance to these drugs has grown prevalent. Their wide range of cellular functions make them ideal targets for antimicrobial agents. Due to the broad scope of their cellular functions, the task of developing analogues that can selectively overcome the resistance conferred by DHFR enzymes from Halopitys Incurvus Algaen's Bromophenol Compound has posed a significant challenge. To identify the compound's drug-like properties, a pre-filtering process was conducted utilizing the Lipinski rule of five in computational analysis. Subsequently, a molecular docking study was carried out using the Chimera#AutoDock Vina 1.17.3 program between the synthetic compound and DHFR (PDB ID: 2W9S) of S. aeurus and TMP was used as control. The results demonstrated that the synthetic compound displayed a favorable binding affinity with the active site of the target protein DHFR enzyme (PDB ID: 2W9S) similar to the control (TMP).

Keywords

Staphylococcus aeurus Bromophenol DHFR Molecular Docking Molecular Dynamic

🔖

Cite This Article

SHADIDIZAJI, A., ÇINAR, B., CİNİSLİ, K. T., REZAEI, M., SAĞSÖZ, M. E., OKKAY, U., BAYRAM, C., YÖRÜK, M. A., YESİLYURT, F., ALTUNLU, Ö., BURUL, F., ÇELİKEL, P., HACIMÜFTÜOĞLU, A. (2023). In silico study of synthetic Bromophenol Compounds against Staphylococcus aeurus's target protein (DHFR) Enzyme. Recent Trends in Pharmacology, Cilt: 1 Sayı: 2, 72–85. https://ajindex.com/articles/1016084

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (8)

Alqahtani, S. (2017). In silico ADME-Tox modeling: progress and prospects. Expert opinion on drug metabolism & toxicology, 13(11), 1147-1158.
Bakchi, B., Krishna, A. D., Sreecharan, E., Ganesh, V. B. J., Niharika, M., Maharshi, S.,. & Shaik, A. B. (2022). An overview on applications of SwissADME web tool in the design and development of anticancer, antitubercular and antimicrobial agents: A medicinal chemist's perspective. Journal of Molecular Structure, 1259, 132712. Bietz, S., Urbaczek, S., Schulz, B., & Rarey, M. (2014). Protoss: a holistic approach to predict tautomers and protonation states in protein-ligand complexes. Journal of cheminformatics, 6, 1-12.
Bitew, M., Desalegn, T., Demissie, T. B., Belayneh, A., Endale, M., & Eswaramoorthy, R. (2021). Pharmacokinetics and drug-likeness of antidiabetic flavonoids: Molecular docking and DFT study. Plos one, 16(12), e0260853. Bourne, C. R. (2014). Utility of the biosynthetic folate pathway for targets in antimicrobial discovery. Antibiotics, 3(1), 1-28.
Chan, Y. G., Frankel, M. B., Dengler, V., Schneewind, O., & Missiakas, D. (2013). Staphylococcus aureus mutants lacking the LytR-CpsA-Psr family of enzymes release cell wall teichoic acids into the extracellular medium. Journal of bacteriology, 195(20), 4650-4659.
Charest, M. G., Lerner, C. D., Brubaker, J. D., Siegel, D. R., & Myers, A. G. (2005). A convergent enantioselective route to structurally diverse 6-deoxytetracycline antibiotics. Science, 308(5720), 395-398.
Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific reports, 7(1), 42717. Dong, H., Dong, S., Erik Hansen, P., Stagos, D., Lin, X., & Liu, M. (2020). Progress of bromophenols in marine algae from 2011 to 2020: Structure, bioactivities, and applications. Marine drugs, 18(8), 411. Ertl, P., & Schuffenhauer, A. (2009). Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions. Journal of cheminformatics, 1, 1-11.
Fisher, J. F., & Mobashery, S. (2020). β-Lactams against the Fortress of the Gram-Positive Staphylococcus aureus Bacterium. Chemical reviews, 121(6), 3412-3463.
Gfeller, D., Grosdidier, A., Wirth, M., Daina, A., Michielin, O., & Zoete, V. (2014). SwissTargetPrediction: a web server for target prediction of bioactive small molecules. Nucleic acids research, 42(W1), W32-W38. Ghosh, S., Das,